Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)

China flag China · Delayed Price · Currency is CNY
4.730
-0.330 (-6.52%)
Apr 10, 2026, 1:45 PM CST
Market Cap3.97B +39.3%
Revenue (ttm)1.91B -20.5%
Net Income-234.63M
EPS-0.30
Shares Out784.39M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume120,167,367
Average Volume58,640,151
Open4.870
Previous Close5.060
Day's Range4.640 - 4.950
52-Week Range3.230 - 5.270
Beta0.30
RSI61.45
Earnings DateApr 23, 2026

About SHA:600594

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, analgesic, cancer, orthopedics, digestion, andrology, and urology. The company also engages in investme... [Read more]

Sector Healthcare
Founded 1995
Employees 5,261
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600594
Full Company Profile

Financial Performance

Financial Statements